Guardant Health to Report Q4 and Full Year 2025 Financials

Got story updates? Submit your updates here. ›

Guardant Health, a leading precision oncology company, announced that it will report its fourth quarter and full year 2025 financial results on February 19, 2026. The company, based in Palo Alto, California, develops blood tests to detect cancer at earlier stages.

Why it matters

As a prominent biotech firm, Guardant Health's financial performance is closely watched by investors and industry analysts. The company's earnings report will provide insights into its business momentum, product adoption, and overall market trends in the precision oncology space.

The details

Guardant Health will host a conference call and webcast on February 19, 2026 at 4:30 p.m. Eastern Time to discuss the financial results and provide a business update. Details on how to access the call will be available on the company's website closer to the reporting date.

• Guardant Health will report Q4 and full year 2025 financial results on February 19, 2026.

What’s next

Investors and analysts will be closely watching Guardant Health's earnings report for insights into the company's growth trajectory and competitive positioning in the precision oncology market.